These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36446913)

  • 1. Oligodendrocytes take centre stage in APOE4-linked Alzheimer disease.
    Kingwell K
    Nat Rev Drug Discov; 2023 Jan; 22(1):15. PubMed ID: 36446913
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E ε4 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease.
    Cheng GW; Mok KK; Yeung SH; Kofler J; Herrup K; Tse KH
    J Neuropathol Exp Neurol; 2022 Aug; 81(9):717-730. PubMed ID: 35779013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.
    Argyri L; Dafnis I; Theodossiou TA; Gantz D; Stratikos E; Chroni A
    J Biol Chem; 2014 May; 289(18):12931-45. PubMed ID: 24644280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
    Sun X; Chiu CC; Liebson E; Crivello NA; Wang L; Claunch J; Folstein M; Rosenberg I; Mwamburi DM; Peter I; Qiu WQ
    Alzheimer Dis Assoc Disord; 2009; 23(3):238-44. PubMed ID: 19812466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's risk variant APOE4 linked to myelin-assembly malfunction.
    Carlström K; Castelo-Branco G
    Nature; 2022 Nov; 611(7937):670-671. PubMed ID: 36385282
    [No Abstract]   [Full Text] [Related]  

  • 7. APOE4-mediated Alzheimer disease and "Vascular"-"Meningeal Lymphatic" components: towards a novel therapeutic era?
    Chen Z; Schwulst SJ; Mentis AA
    Mol Psychiatry; 2021 Oct; 26(10):5472-5474. PubMed ID: 34376823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
    Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
    J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.
    Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC;
    Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics.
    Kaufer D; Gandy S
    Neurology; 2009 Dec; 73(24):2052-3. PubMed ID: 19923549
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
    Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
    J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
    Prasad H; Rao R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.
    Qiu WW; Lai A; Mon T; Mwamburi M; Taylor W; Rosenzweig J; Kowall N; Stern R; Zhu H; Steffens DC
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):177-85. PubMed ID: 23567418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.
    Jung JH; Jeon S; Baik K; Lee YH; Chung SJ; Yoo HS; Jeong SH; Sohn YH; Lee PH; Ye BS
    Neurobiol Aging; 2021 Oct; 106():45-54. PubMed ID: 34242895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.
    Jeong W; Lee H; Cho S; Seo J
    Mol Cells; 2019 Nov; 42(11):739-746. PubMed ID: 31711277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.